SPY334.33+2.22 0.67%
DIA273.90+1.90 0.70%
IXIC11,108.07+109.67 1.00%

Morgan Stanley Initiates Coverage On Cabaletta Bio with Overweight Rating, Announces $19 Price Target

Morgan Stanley initiates coverage on Cabaletta Bio (NASDAQ:CABA) with a Overweight rating and a $19 price target.

Benzinga · -

Morgan Stanley initiates coverage on Cabaletta Bio (NASDAQ:CABA) with a Overweight rating and a $19 price target.